Literature DB >> 21614583

Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B.

Anastazia M Older Aguilar1, Lisbeth A Guethlein, Meike Hermes, Lutz Walter, Peter Parham.   

Abstract

Human killer cell immunoglobulin-like receptors (KIR) recognize A3/11, Bw4, C1, and C2 epitopes carried by mutually exclusive subsets of human leukocyte antigen (HLA)-A, -B, and -C allotypes. Chimpanzee and orangutan have counterparts to HLA-A, -B, and -C, and KIR that recognize the A3/11, Bw4, C1, and C2 epitopes, either individually or in combination. Because rhesus macaque has counterparts of HLA-A and -B, but not HLA-C, we expected that rhesus KIR would better recognize HLA-A and -B, than HLA-C. Comparison of the interactions of nine rhesus KIR3D with 95 HLA isoforms, showed the KIR have broad specificity for HLA-A, -B, and -C, but vary in avidity. Considering both the strength and breadth of reaction, HLA-C was the major target for rhesus KIR, followed by HLA-B, then HLA-A. Strong reactions with HLA-A were restricted to the minority of allotypes carrying the Bw4 epitope, whereas strong reactions with HLA-B partitioned between allotypes having and lacking Bw4. Contrasting to HLA-A and -B, every HLA-C allotype bound to the nine rhesus KIR. Sequence comparison of high- and low-binding HLA allotypes revealed the importance of polymorphism in the helix of the α(1) domain and the peptide-binding pockets. At peptide position 9, nonpolar residues favor binding to rhesus KIR, whereas charged residues do not. Contrary to expectation, rhesus KIR bind more effectively to HLA-C, than to HLA-A and -B. This property is consistent with major histocompatibility complex (MHC)-C having evolved in hominids to be a generally superior ligand for KIR than MHC-A and MHC-B.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21614583      PMCID: PMC3718024          DOI: 10.1007/s00251-011-0535-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  30 in total

1.  Evolutionary patterns of killer cell Ig-like receptor genes in Old World monkeys.

Authors:  Catalina Palacios; Laura C Cuervo; Luis F Cadavid
Journal:  Gene       Date:  2010-12-24       Impact factor: 3.688

Review 2.  Primate-specific regulation of natural killer cells.

Authors:  Peter Parham; Laurent Abi-Rached; Lilit Matevosyan; Achim K Moesta; Paul J Norman; Anastazia M Older Aguilar; Lisbeth A Guethlein
Journal:  J Med Primatol       Date:  2010-08       Impact factor: 0.667

Review 3.  Species-specific evolution of MHC class I genes in the higher primates.

Authors:  E J Adams; P Parham
Journal:  Immunol Rev       Date:  2001-10       Impact factor: 12.988

Review 4.  The KIR and CD94/NKG2 families of molecules in the rhesus monkey.

Authors:  M L LaBonte; K L Hershberger; B Korber; N L Letvin
Journal:  Immunol Rev       Date:  2001-10       Impact factor: 12.988

5.  Rhesus macaque inhibitory and activating KIR3D interact with Mamu-A-encoded ligands.

Authors:  Cornelia Rosner; Philip H Kruse; Meike Hermes; Nicole Otto; Lutz Walter
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

6.  Characterization of rhesus macaque KIR genotypes and haplotypes.

Authors:  Philip H Kruse; Cornelia Rosner; Lutz Walter
Journal:  Immunogenetics       Date:  2010-03-02       Impact factor: 2.846

7.  Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells.

Authors:  Anastazia M Older Aguilar; Lisbeth A Guethlein; Erin J Adams; Laurent Abi-Rached; Achim K Moesta; Peter Parham
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

8.  Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.

Authors:  Laurent Abi-Rached; Achim K Moesta; Raja Rajalingam; Lisbeth A Guethlein; Peter Parham
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

Review 9.  Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  Cancer Biol Ther       Date:  2009-12-28       Impact factor: 4.742

10.  The IMGT/HLA database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

View more
  14 in total

1.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

Review 2.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

3.  The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assay.

Authors:  Hugo G Hilton; Achim K Moesta; Lisbeth A Guethlein; Jeroen Blokhuis; Peter Parham; Paul J Norman
Journal:  J Immunol Methods       Date:  2015-06-19       Impact factor: 2.303

Review 4.  Review: Immunogenetics of human placentation.

Authors:  P Parham; P J Norman; L Abi-Rached; H G Hilton; L A Guethlein
Journal:  Placenta       Date:  2011-12-15       Impact factor: 3.481

Review 5.  Co-evolution of MHC class I and variable NK cell receptors in placental mammals.

Authors:  Lisbeth A Guethlein; Paul J Norman; Hugo G Hilton; Peter Parham
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

6.  Degenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by macaque NK cells.

Authors:  Sebastien M Maloveste; Dan Chen; Emma Gostick; Julian P Vivian; Ronald J Plishka; Ranjini Iyengar; Robin L Kruthers; Alicia Buckler-White; Andrew G Brooks; Jamie Rossjohn; David A Price; Bernard A P Lafont
Journal:  J Immunol       Date:  2012-10-05       Impact factor: 5.422

7.  Characterisation of mouse monoclonal antibodies against rhesus macaque killer immunoglobulin-like receptors KIR3D.

Authors:  Meike Hermes; Sandra Weil; Ariane Groth; Ralf Dressel; Joachim Koch; Lutz Walter
Journal:  Immunogenetics       Date:  2012-08-15       Impact factor: 2.846

Review 8.  TLR/NCR/KIR: Which One to Use and When?

Authors:  Simona Sivori; Simona Carlomagno; Silvia Pesce; Alessandro Moretta; Massimo Vitale; Emanuela Marcenaro
Journal:  Front Immunol       Date:  2014-03-19       Impact factor: 7.561

9.  Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.

Authors:  Achim K Moesta; Peter Parham
Journal:  Front Immunol       Date:  2012-11-22       Impact factor: 7.561

10.  Virus encoded MHC-like decoys diversify the inhibitory KIR repertoire.

Authors:  Paola Carrillo-Bustamante; Can Keşmir; Rob J de Boer
Journal:  PLoS Comput Biol       Date:  2013-10-10       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.